Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 203492, 5 pages
http://dx.doi.org/10.1155/2013/203492
Research Article

Tumor Necrosis Factor-Alpha Gene Promoter Region Polymorphism and the Risk of Coronary Heart Disease

1Department of Biochemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan
2Institute of Biomedical and Genetic Engineering, Islamabad 2891, Pakistan

Received 31 August 2013; Accepted 29 September 2013

Academic Editors: S. Mastana and P. Quax

Copyright © 2013 Gul Zareen Asifa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A.-M. Kampoli, D. Tousoulis, C. Antoniades, G. Siasos, and C. Stefanadis, “Biomarkers of premature atherosclerosis,” Trends in Molecular Medicine, vol. 15, no. 7, pp. 323–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Libby, P. M. Ridker, and G. K. Hansson, “Inflammation in atherosclerosis: from pathophysiology to practice,” Journal of the American College of Cardiology, vol. 54, no. 23, pp. 2129–2138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. R. Aprahamian and F. Sam, “Adiponectin in cardiovascular inflammation and obesity,” International Journal of Inflammation, vol. 2011, Article ID 376909, 8 pages, 2011. View at Publisher · View at Google Scholar
  4. Z. Szekanecz, “Pro-inflammatory cytokines in atherosclerosis,” Israel Medical Association Journal, vol. 10, no. 7, pp. 529–530, 2008. View at Google Scholar · View at Scopus
  5. R. R. S. Packard and P. Libby, “Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction,” Clinical Chemistry, vol. 54, no. 1, pp. 24–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Hajeer and I. V. Hutchinson, “Influence of TNFα gene polymorphisms on TNFα production and disease,” Human Immunology, vol. 62, no. 11, pp. 1191–1199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. G. E. Nedwin, S. L. Naylor, A. Y. Sakaguchi et al., “Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization,” Nucleic Acids Research, vol. 13, no. 17, pp. 6361–6373, 1985. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Lee, J. T. Laydon, P. C. McDonnell et al., “A protein kinase involved in the regulation of inflammatory cytokine biosynthesis,” Nature, vol. 372, no. 6508, pp. 739–746, 1994. View at Google Scholar · View at Scopus
  9. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. G. D. Mellick, “TNF Polymorphism and Cardiovascular Disease: TNF gene polymorphism and quantitative traits related to cardiovascular disease: getting to the heart of the matter,” European Journal of Human Genetics, vol. 15, no. 6, pp. 609–611, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. B. L. Goodwin, L. C. Pendleton, M. M. Levy, L. P. Solomonson, and D. C. Eichler, “Tumor necrosis factor-α reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 2, pp. H1115–H1121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Zhang, Y. Park, J. Wu et al., “Role of TNF-α in vascular dysfunction,” Clinical Science, vol. 116, no. 3, pp. 219–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Skoog, W. Dichtl, S. Boquist et al., “Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men,” European Heart Journal, vol. 23, no. 5, pp. 376–383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Skoog, F. M. van't Hooft, B. Kallin et al., “A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α,” Human Molecular Genetics, vol. 8, no. 8, pp. 1443–1449, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Bennet, M. C. van Maarle, J. Hallqvist et al., “Association of TNF-α serum levels and TNFA promoter polymorphisms with risk of myocardial infarction,” Atherosclerosis, vol. 187, no. 2, pp. 408–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sharma, A. Sharma, S. Kumar, S. K. Sharma, and B. Ghosh, “Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-α levels,” American Journal of Respiratory Cell and Molecular Biology, vol. 35, no. 4, pp. 488–495, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Boehm, K. Hauner, J. Grammer et al., “Tumor necrosis factor-α -863 C/A promoter polymorphism affects the inflammatory response after cardiac surgery,” European Journal of Cardio-thoracic Surgery, vol. 40, no. 1, pp. e50–e54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-P. Bayley, T. H. M. Ottenhoff, and C. L. Verweij, “Is there a future for TNF promoter polymorphisms?” Genes and Immunity, vol. 5, no. 5, pp. 315–329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Elahi, K. Asotra, B. M. Matata, and S. S. Mastana, “Tumor necrosis factor alpha—308 gene locus promoter polymorphism: an analysis of association with health and disease,” Biochimica et Biophysica Acta, vol. 1792, no. 3, pp. 163–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Ledru, P. Ducimetiere, S. Battaglia et al., “New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study,” Journal of the American College of Cardiology, vol. 37, no. 6, pp. 1543–1550, 2001. View at Google Scholar
  21. WHO Expert Consultation, “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies,” The Lancet, vol. 363, pp. 157–163, 2004. View at Google Scholar
  22. L. Ghazouani, S.-B. Khalifa, N. Abboud et al., “-308G>A and -1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease,” Clinical Chemistry and Laboratory Medicine, vol. 47, no. 10, pp. 1247–1251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Oda, N. Tanaka, T. Arai et al., “Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases,” Human Molecular Genetics, vol. 16, no. 6, pp. 592–599, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-B. Liang, M.-L. Lv, X.-W. Su et al., “Association of tumor necrosis factor gene polymorphisms with susceptibility to dilated cardiomyopathy in a Han Chinese population,” DNA and Cell Biology, vol. 29, no. 10, pp. 625–628, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kamoun, H. Chelbi, M. H. Houman, J. Lacheb, and K. Hamzaoui, “Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease,” Human Immunology, vol. 68, no. 3, pp. 201–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. P.-X. Xiang, Y. Li, and P.-A. Zhang, “Tumor necrosis factor-alpha gene polymorphisms and risk of coronary heart disease,” Yi Chuan, vol. 26, no. 6, pp. 807–810, 2004. View at Google Scholar · View at Scopus
  27. W. Koch, K. Tiroch, N. von Beckerath, A. Schömig, and A. Kastrati, “Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting,” Cytokine, vol. 24, no. 4, pp. 161–171, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. P. E. Morange, D. A. Tregouet, T. Godefroy et al., “Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: The AtheroGene Study,” Journal of Molecular Medicine, vol. 86, no. 10, pp. 1153–1161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Baseggio, L. Bartholin, A. Chantome, C. Charlot, R. Rimokh, and G. Salles, “Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter,” European Journal of Immunogenetics, vol. 31, no. 1, pp. 15–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Higuchi, N. Seki, S. Kamizono et al., “Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese,” Tissue Antigens, vol. 51, no. 6, pp. 605–612, 1998. View at Google Scholar · View at Scopus
  31. D. A. van Heel, I. A. Udalova, A. P. De Silva et al., “Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-ΚB transcription factors,” Human Molecular Genetics, vol. 11, no. 11, pp. 1281–1289, 2002. View at Google Scholar · View at Scopus
  32. I. A. Udalova, A. Richardson, A. Denys et al., “Functional consequences of a polymorphism affecting NF-κB p50-p50 binding to the TNF promoter region,” Molecular and Cellular Biology, vol. 20, no. 24, pp. 9113–9119, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Skoog, A. Hamsten, and P. Eriksson, “Allele-specific chromatin remodeling of the tumor necrosis factor-α promoter,” Biochemical and Biophysical Research Communications, vol. 351, no. 3, pp. 777–783, 2006. View at Publisher · View at Google Scholar · View at Scopus